Taken together with the study conducted by Cheon and colleagues [50], upregulation of ECM components and NF-κB pathway due to AEBP1 overexpression could serve as a plausible module for AEBP1-mediated tumorigenesis in ovarian cancer. The gene discussed is NFKB1; the disease is ovarian cancer.